NIR fluorescence imaging and treatment for cancer immunotherapy. Kang, H., Kang, M., Kashiwagi, S., & Choi, H. S. Journal for ImmunoTherapy of Cancer, 10(7):e004936, July, 2022. Publisher: BMJ Specialist Journals Section: Review![NIR fluorescence imaging and treatment for cancer immunotherapy [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Cancer immunotherapy has emerged as one of the most powerful anticancer therapies. However, the details on the interaction between tumors and the immune system are complicated and still poorly understood. Optical fluorescence imaging is a technique that allows for the visualization of fluorescence-labeled immune cells and monitoring of the immune response during immunotherapy. To this end, near-infrared (NIR) light has been adapted for optical fluorescence imaging because it is relatively safe and simple without hazardous ionizing radiation and has relatively deeper tissue penetration into living organisms than visible fluorescence light. In this review, we discuss state-of-the-art NIR optical imaging techniques in cancer immunotherapy to observe the dynamics, efficacy, and responses of the immune components in living organisms. The use of bioimaging labeling techniques will give us an understanding of how the immune system is primed and ultimately developed.
@article{kang_nir_2022,
title = {{NIR} fluorescence imaging and treatment for cancer immunotherapy},
volume = {10},
copyright = {© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.},
issn = {2051-1426},
url = {https://jitc.bmj.com/content/10/7/e004936},
doi = {10.1136/jitc-2022-004936},
abstract = {Cancer immunotherapy has emerged as one of the most powerful anticancer therapies. However, the details on the interaction between tumors and the immune system are complicated and still poorly understood. Optical fluorescence imaging is a technique that allows for the visualization of fluorescence-labeled immune cells and monitoring of the immune response during immunotherapy. To this end, near-infrared (NIR) light has been adapted for optical fluorescence imaging because it is relatively safe and simple without hazardous ionizing radiation and has relatively deeper tissue penetration into living organisms than visible fluorescence light. In this review, we discuss state-of-the-art NIR optical imaging techniques in cancer immunotherapy to observe the dynamics, efficacy, and responses of the immune components in living organisms. The use of bioimaging labeling techniques will give us an understanding of how the immune system is primed and ultimately developed.},
language = {en},
number = {7},
urldate = {2023-11-06},
journal = {Journal for ImmunoTherapy of Cancer},
author = {Kang, Homan and Kang, Min-Woong and Kashiwagi, Satoshi and Choi, Hak Soo},
month = jul,
year = {2022},
pmid = {35858710},
note = {Publisher: BMJ Specialist Journals
Section: Review},
keywords = {adjuvants, pharmaceutic, biomarkers, tumor, cell engineering, immunotherapy},
pages = {e004936},
}
Downloads: 0
{"_id":"vh5Q8vrfCs83PdP6o","bibbaseid":"kang-kang-kashiwagi-choi-nirfluorescenceimagingandtreatmentforcancerimmunotherapy-2022","author_short":["Kang, H.","Kang, M.","Kashiwagi, S.","Choi, H. S."],"bibdata":{"bibtype":"article","type":"article","title":"NIR fluorescence imaging and treatment for cancer immunotherapy","volume":"10","copyright":"© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.","issn":"2051-1426","url":"https://jitc.bmj.com/content/10/7/e004936","doi":"10.1136/jitc-2022-004936","abstract":"Cancer immunotherapy has emerged as one of the most powerful anticancer therapies. However, the details on the interaction between tumors and the immune system are complicated and still poorly understood. Optical fluorescence imaging is a technique that allows for the visualization of fluorescence-labeled immune cells and monitoring of the immune response during immunotherapy. To this end, near-infrared (NIR) light has been adapted for optical fluorescence imaging because it is relatively safe and simple without hazardous ionizing radiation and has relatively deeper tissue penetration into living organisms than visible fluorescence light. In this review, we discuss state-of-the-art NIR optical imaging techniques in cancer immunotherapy to observe the dynamics, efficacy, and responses of the immune components in living organisms. The use of bioimaging labeling techniques will give us an understanding of how the immune system is primed and ultimately developed.","language":"en","number":"7","urldate":"2023-11-06","journal":"Journal for ImmunoTherapy of Cancer","author":[{"propositions":[],"lastnames":["Kang"],"firstnames":["Homan"],"suffixes":[]},{"propositions":[],"lastnames":["Kang"],"firstnames":["Min-Woong"],"suffixes":[]},{"propositions":[],"lastnames":["Kashiwagi"],"firstnames":["Satoshi"],"suffixes":[]},{"propositions":[],"lastnames":["Choi"],"firstnames":["Hak","Soo"],"suffixes":[]}],"month":"July","year":"2022","pmid":"35858710","note":"Publisher: BMJ Specialist Journals Section: Review","keywords":"adjuvants, pharmaceutic, biomarkers, tumor, cell engineering, immunotherapy","pages":"e004936","bibtex":"@article{kang_nir_2022,\n\ttitle = {{NIR} fluorescence imaging and treatment for cancer immunotherapy},\n\tvolume = {10},\n\tcopyright = {© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.},\n\tissn = {2051-1426},\n\turl = {https://jitc.bmj.com/content/10/7/e004936},\n\tdoi = {10.1136/jitc-2022-004936},\n\tabstract = {Cancer immunotherapy has emerged as one of the most powerful anticancer therapies. However, the details on the interaction between tumors and the immune system are complicated and still poorly understood. Optical fluorescence imaging is a technique that allows for the visualization of fluorescence-labeled immune cells and monitoring of the immune response during immunotherapy. To this end, near-infrared (NIR) light has been adapted for optical fluorescence imaging because it is relatively safe and simple without hazardous ionizing radiation and has relatively deeper tissue penetration into living organisms than visible fluorescence light. In this review, we discuss state-of-the-art NIR optical imaging techniques in cancer immunotherapy to observe the dynamics, efficacy, and responses of the immune components in living organisms. The use of bioimaging labeling techniques will give us an understanding of how the immune system is primed and ultimately developed.},\n\tlanguage = {en},\n\tnumber = {7},\n\turldate = {2023-11-06},\n\tjournal = {Journal for ImmunoTherapy of Cancer},\n\tauthor = {Kang, Homan and Kang, Min-Woong and Kashiwagi, Satoshi and Choi, Hak Soo},\n\tmonth = jul,\n\tyear = {2022},\n\tpmid = {35858710},\n\tnote = {Publisher: BMJ Specialist Journals\nSection: Review},\n\tkeywords = {adjuvants, pharmaceutic, biomarkers, tumor, cell engineering, immunotherapy},\n\tpages = {e004936},\n}\n\n","author_short":["Kang, H.","Kang, M.","Kashiwagi, S.","Choi, H. S."],"key":"kang_nir_2022","id":"kang_nir_2022","bibbaseid":"kang-kang-kashiwagi-choi-nirfluorescenceimagingandtreatmentforcancerimmunotherapy-2022","role":"author","urls":{"Paper":"https://jitc.bmj.com/content/10/7/e004936"},"keyword":["adjuvants","pharmaceutic","biomarkers","tumor","cell engineering","immunotherapy"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/natzem","dataSources":["pa4CjeiS7oDnQDkEc"],"keywords":["adjuvants","pharmaceutic","biomarkers","tumor","cell engineering","immunotherapy"],"search_terms":["nir","fluorescence","imaging","treatment","cancer","immunotherapy","kang","kang","kashiwagi","choi"],"title":"NIR fluorescence imaging and treatment for cancer immunotherapy","year":2022}